China Medical Share Discussion Threads

[azalea] 17/11/2009 14:47

Buyers moving in fairly quickly, 400p looks like offering little resistance as MM under pressure to find stock are upping the share price accordingly.

[boadicea] 17/11/2009 13:20

Like cestnous - I topped some at 410p and hoped to see it back at 325p to buy them back.
Question now is patience or surrender to the higher cost?
Retraces in this share are unpredictable and tend to be surprisingly minimal.

[boadicea] 17/11/2009 13:18

(Deleted double entry)

[drewdrops] 17/11/2009 12:52

Toe = dipped at 365

[azalea] 17/11/2009 12:39

All abooaard.

[azalea] 17/11/2009 09:42

Are we going to see buyers appear, or news to account for the tick up on just the 100 shares bought?

Edit: Oops, no sooner did I speak and hey presto!

cestnous, Bang goes your re-entry price

[cestnous] 16/11/2009 16:21

Took profits @400. Looking to get back in between 300 and 325 but will wait for new consolidation point

[dasv] 16/11/2009 16:01

azalea - thanks for those forecasts - very juicy EPS. I may pick up a few more then..

[drewdrops] 16/11/2009 15:45

once this retrace is settled gonna take the plunge...

[azalea] 16/11/2009 13:05

2/11/09,Seymour Pierce forecasted 2009 Ptx £15.42m Eps 26.14p(with a buy recc),notably up on its forecast 1/5/09.

6/8/09 Equity Development forecasted 2010 Ptx £21.56m Eps 33.97p(no recc).

[dasv] 16/11/2009 12:48

You have to put a thumb in the air estimate on next year's earnings - in my view the earnings growth supports a much higher PER than current share price suggests however after a swift rise like that a pull back is almost inevitable.

[longsight] 16/11/2009 11:19

dasv - I am an ignoramus on this share but a low per in comparison with China healthcare stocks from what I can see. Bit of a paucity of info on these so difficult perhaps to evaluate a good price for them. I wonder how many holders thought they wd go up so much in % terms but still might be cheap.

[dasv] 16/11/2009 10:42

longsight - profit taking I reckon.

[azalea] 16/11/2009 09:46

Excellent buying opportunity after the recent dip, in for 2k.

[longsight] 16/11/2009 08:43

Down 24% since Nov 5 - anyone know why?

[dasv] 10/11/2009 14:57

400 support held - promising...

[dasv] 06/11/2009 11:11

I just sold half at 410. Musn't be greedy.

[nfs] 06/11/2009 10:03

At £200m mkt cap I think the rating is toppy for now

[kiwi10] 04/11/2009 21:39

has anyone had a look into amei....an african medical group that looks like it is expanding the right way ....i am not trying to ramp it but was wondering if anyone has had a look at at.....thanks....regards

[dasv] 04/11/2009 18:37

I have WCC too - I have also heard good things about SFT.

[boadicea] 04/11/2009 17:47

dasv - Re: Your question - Has been answered comprehensively by others while I was out, quoting the same shares I would have come up with.

In the case of RCG the share ownership as such worries me less than how it came about and how we learned of it. However, the current share price discounts almost any negatives you could dream up - and many have tried doing that! The company is obviously much better at selling to customers than to shareholders.

CHNS hasn't actually passed an annual dividend but is not making an interim one and will assess the situation against capital needs and availability of finance (they are investing in a new recycling plant) when the year's outcome is in the bag.

My only addition would be SFT which has a generous balance sheet but, as a supplier of tax software progressing on a regional basis, has suffered roll-out delays. It is shown as yielding 3.35% (by advfn - so check it!) Successful diversification is progressing and there is very ample room for appreciation with funds to back expansion. (Imho/dyor etc.)

[dasv] 04/11/2009 17:15

That's a good point about the dividend penpont.

With respect to dividend yields in general, one thing I've never understood about the Nikkei is the very weak dividend yield - puts me off investing in it. I guess they get away with it because japanese gov bond yields pay such little interest...

[penpont] 04/11/2009 15:48

There are a couple of things that could possibly account for the higher rating here.

- High div yield and more important, a stated, committed, strongly progressive div. growth policy. Lamentably few London listed Cos have this, let alone Chinese ones, and it has to be said that both CHNS and RCG have both slightly shot themselves in the foot over their handling of dividends since coming to market.

-Their drug development canditates could be a real kicker at some stage. A licencing deal with a major pharma is a possibility and I've wondered if some positive news might be in the offing regarding this.

-They have in the past beaten expectations and could conceivably do 40p for next year rather than the 34p expected, leaving them on a prosp PE of around 10 - still not that expensive for a reasonably recession proof medical stock.

I've been taken aback at the extent of the rise but am not selling - unless of course the story changes for the worse. This seems like the classic kind of stock that could be very difficult to buy back into once out....